SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMD is surging as investors react to a positive price target hike and a series of strategic multi-year deals aimed at expanding its AI infrastructure footprint. The community is heavily focused on the stock's robust momentum, with many traders debating the likelihood of a continued squeeze toward higher price levels versus potential overbought conditions.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

Hims & Hers Health is experiencing a strong rally fueled by optimistic community sentiment regarding the potential FDA reclassification of several peptides, which could significantly expand the company's product offerings and addressable market. Investors are actively discussing the stock's high short interest and technical breakouts, leading many to speculate that a potential short squeeze could drive the share price toward higher resistance levels.

MARA Holdings, Inc. is a digital asset technology company, which engages in mining cryptocurrencies with a focus on the Bitcoin ecosystem. It also deals with owning and operating bitcoin mining facilities or data centers, selling proprietary software or technology to third parties operating in the Bitcoin ecosystem, offering advisory and consulting services to support Bitcoin mining ventures in domestic and international jurisdictions, and generating electricity from renewable energy resources or methane gas capture to power Bitcoin mining projects. The company was founded on February 23, 2010 and is headquartered in Hallandale Beach, FL.

MARA Holdings Inc.

Marathon Digital Holdings Inc

Marathon Digital Holdings is trending as investors react to the company's pivot toward AI infrastructure and high-performance computing, while community members actively discuss its potential for a short squeeze amid high short interest. Market participants remain sharply divided, with some highlighting the company's strategic bitcoin balance sheet management and energy assets, while others express frustration over historical stock performance and leadership.

Navitas Semiconductor Corp. engages in the development of ultra-efficient gallium nitride (GaN) semiconductors. Its GaN power ICs integrate GaN power with drive, control and protection to enable charging, power density, and energy savings for mobile, consumer, enterprise, eMobility and new energy markets. The company was founded by Daniel Kinzer, Nick Fichtenbaum, Gene Sheridan, and Jason Zhang on August 12, 2020 and is headquartered in Torrance, CA.

Navitas Semiconductor Corp

Navitas Semiconductor is trending as traders analyze its strategic position in AI data center power infrastructure, particularly regarding its 800V power delivery solutions for next-gen AI hardware. The community remains deeply divided between bullish sentiment fueled by potential integration into major AI ecosystems and skepticism driven by stock volatility, consolidation patterns, and a desire for more transparent contract announcements.

Newcourt Acquisition Corp. is a blank check company, which engages in the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 25, 2021 and is headquartered in Oakland, CA.

Psyence Biomedical Ltd.

Psyence Biomedical is generating significant market activity as traders react to reports of a potential Trump administration executive order aimed at advancing psychedelic research for PTSD, which is fueling high-volatility price swings and speculation about a short squeeze on its low-float shares. While bulls are focused on the narrative of an emerging sector catalyst and the potential for rapid gains, others in the community are voicing skepticism regarding the company's history of reverse splits and dilution, leading to intense debate over the stock's long-term sustainability.

Taiwan Semiconductor Manufacturing Co., Ltd. engages in the manufacture and sale of integrated circuits and wafer semiconductor devices. Its chips are used in personal computers and peripheral products, information applications, wired and wireless communications systems products, and automotive and industrial equipment including consumer electronics such as smartphones, digital television, game consoles, and digital cameras. The company was founded by Chung Mou Chang on February 21, 1987 and is headquartered in Hsinchu, Taiwan.

Taiwan Semiconductor Manufacturing - ADR

TSM is currently trending as investors digest record-breaking Q1 earnings and robust AI-driven guidance, even as broader market volatility and geopolitical concerns fuel debates over the stock's valuation. The community is intensely focused on the company's ability to maintain its leading-edge manufacturing dominance despite increased capital expenditure and persistent supply chain headwinds.

Operates as a holding company with interest in providing social shopping platform solutions

WeShop Holdings Ltd - Ordinary Shares - Class A

WeShop Holdings Limited

WeShop Holdings Limited is currently experiencing intense volatility and community speculation as traders identify it as a high-squeeze, low-float candidate prone to rapid price spikes. The conversation is heavily focused on the stock's potential for parabolic movement, with many participants actively comparing it to other recent momentum plays and debating the sustainability of its sharp price fluctuations.

Xanadu Quantum Technologies Ltd. engages in the provision of quantum computing solutions for enterprise and government customers. The company was founded by Christian Weedbrook on October 2, 2025 and is headquartered in Toronto, Canada.

Xanadu Quantum Technologies Ltd. - Ordinary Shares - Class B (Sub Voting)

Xanadu Quantum Technologies is capturing significant attention as investors react to its recent public listing, with the community actively debating its potential as a pure-play photonic quantum leader against significant debt and early-stage revenue challenges. Traders are closely monitoring the stock's high volatility and low-float dynamics, with many discussing the potential for short squeezes alongside speculation about future institutional partnerships and government funding.

Julong Holding Ltd. engages in the business of investment holding activities. It provides intelligent integrated solutions to public utilities, enterprises, commercial, and multifamily properties. The company was founded by Jia Qi Hu on August 07, 2023 and is headquartered in Beijing, China.

Julong Holding Ltd. - Ordinary Shares - Class A

Julong Holding Ltd. is trending as a low-float Chinese micro-cap play, drawing significant attention from day traders seeking quick momentum and potential short squeezes. Community discussions are highly polarized, with many retail participants speculating on parabolic moves and comparing the stock to past market runners, while others warn of the inherent risks associated with high volatility and the potential for rapid price reversals.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

XRP is trending as investors monitor the progress of the CLARITY Act, with community sentiment divided between those anticipating a major regulatory-driven rally and skeptics wary of stagnant price action. The conversation is currently fueled by speculative institutional adoption news and debates over whether Ripple’s utility will finally trigger a decoupling from broader crypto market volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Promising Medical Stocks To Follow Now - April 16th

Abbott Laboratories, Hims & Hers Health, and Eli Lilly and Company are the three Medical stocks to watch today, according to MarketBeat's stock screener tool. Medical stocks are shares of publicly...

Best Healthcare Stocks To Watch Now - April 16th

Hims & Hers Health, Johnson & Johnson, UnitedHealth Group, Intuitive Surgical, Medtronic, Tempus AI, and Becton, Dickinson and Company are the seven Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly traded companies that operat...

Danaher Gears Up to Post Q1 Earnings: What Lies Ahead for the Stock?

DHR heads into Q1 results with rising bioprocessing demand and steady estimates, but cost pressures and FX headwinds could weigh on performance.

Hims & Hers Health (NYSE:HIMS) Shares Gap Up After Analyst Upgrade

Hims & Hers Health (NYSE:HIMS) Shares Gap Up After Analyst Upgrade...

HIMS Plunges 51.2% in 6 Months: Should You Still Hold the Stock or Sell?

Hims & Hers rolls out Benefits and taps Novo Nordisk for GLP therapies in weight-loss care as revenue grows, but margins and cash flow tighten.

Bank of America Issues Positive Forecast for Hims & Hers Health (NYSE:HIMS) Stock Price

Bank of America upped their price target on shares of Hims & Hers Health from $21.00 to $25.00 and gave the company a "neutral" rating in a report on Thursday...

<ul class="summary-bullets"><li>&nbsp;Benchmark indices scaled fresh milestones, with the S&amp;P 500 topping 7,000 on Wednesday.</li><li>Easing Middle East tensions and strong tech momentum lifted retail sentiment.</li><li>Investors are now bracing for a slate of earnings and economic data that could determine whether the momentum can be sustained.</li></ul>U.S. stock futures were higher early Thursday as Wall Street looked to extend a rally that pushed the S&amp;P 500 above the 7,000 mark and the Nasdaq past 26,000 in the previous session. Investors are monitoring easing geopolitical tensions in the Middle East with a slate of top-tier earnings and macro data due today.As of 4:00 a.m. ET on Thursday, Nasdaq futures rose 0.4%, S&amp;P 500 futures gained 0.2%, and Dow and Russell 2000 futures were up 0.1%.&nbsp;Retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF (SPY)</a>, an exchange-traded fund that tracks the S&amp;P 500 Index, has flipped to ‘bullish’ from ‘neutral’ a day ago, and the&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> ETF, which tracks the Nasdaq-100 Index, has remained ‘bullish’,&nbsp; fueled by a rally in quantum computing stocks.Trending Stocks To WatchTaiwan Semiconductor Manufacturing Co (TSM):&nbsp;Nvidia's chip supplier reported a record Q1 profit jump of 58%, crushing estimates. For the second quarter, TSM expects revenue of $39 billion to $40.2 billion and a gross margin of 65.5% to 67.5%.Nvidia (NVDA): CEO&nbsp;Jensen Huang downplayed the concerns on growing speculation that the bellwether’s dominance in AI compute is vulnerable to rival Google’s TPUs and Amazon’s Trainium chips or others. The stock seems on track for its 12th straight session of gains.Hims &amp; Hers Health (HIMS):&nbsp;Shares rose nearly 10% in early pre-market trade after&nbsp;Health and Human Services Secretary Robert F. Kennedy Jr.&nbsp;indicated the FDA would reclassify 12 peptides, reducing perceived safety risks for the company’s product pipeline.Netflix (NFLX):&nbsp;Trading at multi-year highs ahead of its Q1 report after it lost the race to acquire Warner Bros Discovery (WBD). Analyst focus remains on subscriber growth and ad-tier traction, which comes after Netflix raised its subscription prices for the second time last month.&nbsp;PayPal (PYPL): The stock is trending after Michael Burry expressed confidence in a recovery in the software and payments sector, suggesting the recent sell-off was overextended.Allbirds Inc (BIRD):&nbsp;The stock saw a sharp reversal in early premarket trading after soaring over 500% the previous day, following its surprise pivot to an AI infrastructure play. William Blair has dropped coverage, warning the stock's explosive rally was fueled by speculative hype.Watch out for oil stocks (XOM, CVX)&nbsp;in trade today. The White House will host a call with U.S. oil executives on Thursday.Other tickers trending on&nbsp;Stocktwits&nbsp;at the time of writing included Advanced Micro Devices (AMD), AST SpaceMobile (ASTS), Sofi Technologies (SOFI), and Microsoft (MSFT).Other Catalysts To WatchOn the economic front, traders will be watching for the release of Initial Jobless Claims and Philadelphia Fed Manufacturing Index today.On earnings radar, watch out for quarterly reports from&nbsp;PepsiCo, Travelers, U.S. Bancorp, Abbott Labs and Charles Schwab, among others, today.For updates and corrections, email newsroom[at]stocktwits[dot]com

Nasdaq, S&P 500 Futures Edge Higher After Record Rally: Why TSM, NVDA, HIMS, PYPL, BIRD Are Trending Premarket

Data from Stocktwits shows that retail positioning has shifted decisively risk-on for SPY and QQQ. 

Equity

Data from Stocktwits shows that retail positioning has shifted decisively risk-on for SPY and QQQ. 


<ul class="summary-bullets"><li>The FDA scheduled advisory meetings on July 23-24 to review several peptide substances for possible inclusion on the 503A Bulks List.</li><li>BofA raised its price target in HIMS to $25 from $21, citing potential upside from FDA peptide policy developments.</li><li>The FDA review follows 2023 restrictions on nearly 20 peptides over safety concerns.</li></ul>Shares of Hims &amp; Hers Health, Inc. (HIMS) jumped&nbsp;over 10% in premarket trading on Thursday after Bank of America Securities (BofA) raised its price target and flagged potential new revenue upside from upcoming FDA talks that could expand access to peptide therapies beyond GLP-1 treatments.<h2 class="st-heading-2">BofA Sees GLP-1 Capacity Repurposed For Peptides</h2>BofA lifted its price target on Hims to $25 from $21, while maintaining a ‘Neutral’ rating. The firm raised its outlook following a recent notice from the U.S. Food and Drug Administration (FDA) that it is scheduling July 23-24 meetings to review several peptide substances for possible inclusion on the 503A Bulks List, which determines which ingredients pharmacies can legally use to prepare customized medicines.The brokerage said the move could open the door to new potential revenue opportunities for the company. BofA added that the development could allow the company to repurpose existing GLP-1 capacity for other peptide therapies as it transitions its weight-loss strategy toward branded treatments, according to an Investing.com&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.investing.com/news/analyst-ratings/bofa-raises-hims-and-hers-stock-price-target-on-peptide-optionality-93CH-4616805">report</a>.To reflect the additional revenue stream and higher peer multiples, BofA raised its valuation multiple assumption to 25.5x from 21.5x. However, BofA noted that the FDA’s action represents only an initial step, not confirmation that any peptide substances will ultimately be added to the compounding list.&nbsp;<h2 class="st-heading-2">FDA Revisits Peptides Restricted In 2023</h2>The&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-hims-stock-rallying-after-hours/cZJtsDdRIwt">FDA’s upcoming review</a> follows setbacks in 2023, under the Joe Biden administration, to place nearly 20 peptide substances on a federal restriction list preventing their use by compounding pharmacies after advisers concluded the drugs lacked sufficient clinical safety evidence.Regulators at the time cited risks including potential cancer and liver, kidney, and heart complications, noting that many peptides promoted across wellness markets had not been extensively studied in humans.U.S. Health and Human Services Secretary Robert F. Kennedy Jr.&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/SecKennedy/status/2044478939897221219">said on X</a> that the review process is intended to help shift demand away from “a dangerous black market that puts Americans at risk.”&nbsp;<h2 class="st-heading-2">Hims Shifts Toward Branded GLP-1 Treatments</h2>The peptide-linked upside comes as Hims continues shifting its weight-loss business toward FDA-approved branded GLP-1 therapies following its agreement with Novo Nordisk. As part of the deal, the company plans to discontinue marketing compounded GLP-1 alternatives and instead offer Wegovy alongside Ozempic for eligible patients.CEO Andrew Dudum recently said that the company has already shipped its first Novo Nordisk medicines and is&nbsp;on track to exceed a run rate of 100,000 Wegovy prescriptions per month as part of the rollout.&nbsp;<h2 class="st-heading-2">How Do Retail Traders Feel About HIMS?</h2>On Stocktwits, retail sentiment for HIMS jumped to ‘extremely bullish’ from ‘bearish’ levels a day ago amid over a 400% surge in 24-hour message volumes.<figure class="image"><img src="https://news.stocktwits-cdn.com/hims_ss_png_b2da13f7c2.webp" alt="hims ss.png" width="969" height="145"><figcaption>HIMS sentiment and message volume as of April 16 | Source: Stocktwits</figcaption></figure>Several users highlighted high short interest in HIMS shares, which currently hovers near a record high of 36.6%, according to Koyfin data.&nbsp;One user&nbsp;<a href="https://stocktwits.com/MinimalistKLine/message/650436495">said</a>, “Is $HIMS about to melt faces? Probably. With a 30% short interest and massive momentum, we’re looking at a prime short squeeze setup. These are exactly the high-stakes setups we live for. Let the fireworks begin.”<stembedurl>https://stocktwits.com/MinimalistKLine/message/650436495</stembedurl>Another user said, “Interesting day ahead guys. short position must be covered now. too much risk for more positive news to come.”<stembedurl>https://stocktwits.com/Arrie1982/message/650436093</stembedurl>HIMS stock has declined 18% over the past year.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/symbol/HIMS">TSM Stock Spikes Overnight: Q1 Print Tops Estimates On Strong Demand For AI Chips, Advanced Processors</a>

In this photo illustration, a smartphone displays the logo of Hims & Hers Health in front of a screen showing the company's stock market chart. (Photo illustration by Cheng Xin/Getty Images)

HIMS Stock Soars 10% Premarket: BofA Flags Fresh Upside As FDA Peptide Pivot Could Turn GLP-1 Capacity Into New Growth Engine

HIMS Stock - The brokerage added that the shift could allow the company to repurpose existing GLP-1 capacity toward other peptide treatments.

The brokerage added that the shift could allow the company to repurpose existing GLP-1 capacity toward other peptide treatments.


<ul class="summary-bullets"><li>The S&amp;P 500 and Nasdaq Composite closed at fresh record highs on Wednesday.</li><li>Trump said the U.S.-Iran war is “very close to over,” while reports said both sides have an “in principle agreement” to continue diplomacy despite unresolved issues around the Strait of Hormuz and nuclear enrichment.</li><li>Oil steadied near $91 per barrel for WTI and $95 for Brent as Washington and Tehran considered extending a ceasefire.</li></ul>U.S. stock futures edged higher Wednesday night after the S&amp;P 500 and Nasdaq Composite closed at fresh record highs, as investors weighed easing tensions in Iran and expectations for a supportive earnings season.As of 9.10 p.m. ET, Nasdaq 100 futures were up 0.3%, while S&amp;P 500 and Dow futures were up 0.2%.On Stocktwits, retail sentiment toward the&nbsp;<a href="https://stocktwits.com/symbol/SPY">SPDR S&amp;P 500 ETF Trust (SPY)</a>,&nbsp;<a href="https://stocktwits.com/symbol/QQQ">Invesco QQQ Trust (QQQ)</a> and&nbsp;<a href="https://stocktwits.com/symbol/DIA">SPDR Dow Jones Industrial Average ETF Trust (DIA)</a> was ‘bullish’ amid ‘normal’ message volume.<h2 class="st-heading-2">US Market Drivers</h2>Investor sentiment strengthened on Wednesday after U.S. President Donald Trump&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnn.com/2026/04/15/politics/video/trump-tells-fox-business-iran-war-very-close-to-over-vrtc">said</a> in a Fox Business interview that the Iran war is “very close to over” and claimed Tehran wants to “make a deal very badly,” adding to optimism that the conflict may be nearing an end.An initial round of talks between the two sides in Pakistan last weekend failed to yield a deal, though mediators are now working to set up talks to resolve key issues, including reopening the strait and Iran’s nuclear enrichment program. The Associated Press&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://apnews.com/article/us-iran-war-lebanon-israel-talks-hormuz-15-april-2026-f1b02d16f81d6fdcf68c0ed16d7a719d">reported&nbsp;</a>that both sides have an “in principle agreement” to pursue further diplomacy.Oil steadied near $91 per barrel for West Texas Intermediate after Brent settled near $95 as Washington and Tehran considered a possible two-week ceasefire extension to allow more time for negotiations to end the war that has disrupted energy markets.&nbsp;The crude market has remained focused on developments around the Strait of Hormuz, with the U.S. setting up a naval blockade to cut off Iranian traffic while Tehran has kept the waterway closed to most other ships.Iran’s joint military headquarters commander, Ali Abdollahi,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://english.news.cn/20260415/e55acee051c64b679b0c217be5fd9979/c.html">warned</a> that the armed forces would not permit exports or imports to continue in the Persian Gulf, the Sea of Oman, or the Red Sea if the blockade continued.In the previous session, the Nasdaq posted its 11th straight gain, and the S&amp;P 500 advanced in 10 of the past 11 sessions after wiping out all losses from the Iran conflict earlier this week. The S&amp;P 500 has risen about 3% week-to-date, while the Nasdaq has added nearly 5% over the same period.<div><figure class="table"><table class="ck-table-resized"><colgroup><col><col><col></colgroup><tbody><tr><td>Index</td><td>Move</td><td>Close</td></tr><tr><td>Dow Jones Industrial Average</td><td>-0.15%</td><td>48,463.72</td></tr><tr><td>S&amp;P 500</td><td>0.8%</td><td>7,022.95</td></tr><tr><td>Nasdaq Composite</td><td>1.59%</td><td>24,016.02</td></tr></tbody></table></figure></div>Gary Black, managing partner at The Future Fund,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/garyblack00/status/2044513579949232176">said on X</a> that “stocks remain compelling relative to risk-free bonds, and absent the war, could move even higher if the impending earnings season produces further gains in earnings per share (EPS) estimates.”<h2 class="st-heading-2">Trending Stocks To Watch On NYSE, Nasdaq</h2>Hims &amp; Hers Health (HIMS): The stock rose 14% during regular trading and climbed another 10% in extended hours after Health and Human Services Secretary Robert F. Kennedy Jr. said the FDA&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-hims-stock-rallying-after-hours/cZJtsDdRIwt">will remove</a> 12 peptides from the category of drug substances with significant safety risks, a segment the company previously said it is exploring.Microsoft (MSFT): Shares are headed toward its best week in nearly a year as investor sentiment improved after earlier concerns around its positioning in the AI landscape, while U.S. weekly spending on video-game hardware nearly doubled year over year in the week ending April 4, including Xbox Series consoles, according to Circana.Rumble (RUM): The stock hit its highest level in a month on Wednesday and extended its winning streak to three sessions after launching an exchange offer to acquire Northern Data as part of its push to expand cloud infrastructure and AI.Netflix (NFLX): Shares hit their highest levels since December ahead of its first-quarter results after market hours on Thursday, with estimates pointing to revenue of $12.17 billion and GAAP EPS of $1.34.Xanadu Quantum Technologies (XNDU): The stock posted its best day on record on Wednesday as quantum-computing stocks gained following&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rgti-ionq-qbts-qubt-xndu-stocks-surge-on-nvidia-quantum-push/cZJt1ijRIwK">Nvidia’s launch</a> of its Ising quantum AI models aimed at accelerating quantum processor development.<h2 class="st-heading-2">How Global Markets Are Performing Today</h2>In broader markets, the yield on the benchmark 10-year U.S. Treasury note was near 4.3%, while gold traded around $4,812 per ounce.&nbsp;Asian markets were higher, with MSCI’s broadest index outside Japan rising 0.3%, alongside higher open prices in Japan and Australia.Among the catalysts for the day are initial jobless claims, the Philadelphia Fed manufacturing survey, industrial production, capacity utilization and remarks from New York Fed President John Williams and Federal Reserve Governor Stephen Miran.&nbsp;Investors are also watching earnings from Taiwan Semiconductor Manufacturing Company, Netflix, PepsiCo, Abbott Laboratories, The Charles Schwab Corp. and Prologis.For updates and corrections, email newsroom[at]stocktwits[dot]com.

 U.S. President Donald Trump participates in a meeting with fellow G7 leaders during a meeting at the G7 Leaders' Summit on June 16, 2025 in Kananaskis, Alberta. 

Dow, S&P 500, Nasdaq Futures Rise After Trump Says US-Iran War ‘Very Close To Over:’ Why HIMS, MSFT, RUM, NFLX, XNDU Are Trending After-Hours

Wall Street momentum remained strong, with the Nasdaq logging its 11th straight gain and the S&P 500 rising in 10 of the past 11 sessions after recovering losses from the conflict earlier this week.

<ul class="summary-bullets"><li>At two meetings starting in July, independent experts at the Pharmacy Compounding Advisory Committee will rigorously evaluate each substance on its scientific merits, Kennedy said.</li><li>Peptides are a segment that Hims expressed interest in during its last earnings call in February.&nbsp;</li><li>Peptides are frequently utilized in skincare, supplements, and specialized therapeutic treatments.</li></ul>Shares of Hims &amp; Hers Health (HIMS) closed up 14% and edged 11% higher after-hours on Wednesday as the Trump administration contemplates easing the rules around selling peptides.Health and Human Services Secretary Robert F. Kennedy Jr. said in an X post on Wednesday that the U.S. Food and Drug Administration will remove 12 peptides from the category of drug substances with significant safety risks. The previous categorization prohibited compounding pharmacies from making versions of it.<h2 class="st-heading-2">The Rationale</h2>At two meetings starting in July, independent experts at the Pharmacy Compounding Advisory Committee will rigorously evaluate each substance on its scientific merits using full clinical, pharmacological, and safety evidence, the Health Secretary said, adding that the action is aimed at regulating access and shifting demand away from the black market. Peptides are a segment that Hims expressed interest in during its last earnings call in February.Following Kennedy’s post, Hims Chief Medical Office Pat Carroll applauded the move.“Our medical team believes certain peptide therapies hold meaningful potential in helping Americans live healthier lives, and we are actively exploring how to expand access in a way that will be aligned with FDA guidance and reflects our commitment to consumer safety, transparency, and clinical excellence,” Carroll said.Peptides are short chains of amino acids, the building blocks of proteins, used primarily to enhance skin health, build muscle, aid in weight loss, and manage medical conditions. They are frequently utilized in skincare, supplements, and specialized therapeutic treatments.<h2 class="st-heading-2">How Did Retail Traders React?</h2>On Stocktwits, retail sentiment around HIMS stock jumped from ‘bearish’ to ‘bullish’ territory over the past 24 hours, while message volume increased from ‘low’ to ‘high’ levels.A Stocktwits user highlighted the market demand for peptides.<stembedurl>https://www.stocktwits.com/OSheaTrade/message/650417266</stembedurl>Another highlighted the company’s expanding product range and expressed hopes for the stock to rally to $45, and further to $100.<stembedurl>https://www.stocktwits.com/REALAdrian/message/650414976</stembedurl>According to data from Koyfin, three of the 15 analysts covering HIMS rate it ‘Buy’ or higher, while 12 rate it ‘Hold.’ The 12-month average price target on the stock is $24, representing a potential downside of about 1% from last close.<a href="https://stocktwits.com/symbol/HIMS">HIMS stock</a> has lost 18% over the past 12 months.&nbsp;Read More: <a href="https://stocktwits.com/news-articles/markets/equity/svra-stock-slips-post-market-after-fda-delays-decision-on-pulmonary-therapy/cZJtoosRIwA">SVRA Stock Slips Post-Market After FDA Delays Decision On Pulmonary Therapy</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, a person holds a smartphone displaying the logo of Hims & Hers Health Inc. (NYSE: HIMS). (Photo illustration by Cheng Xin/Getty Images)

Why Is HIMS Stock Surging More Than 11% After-Hours Today?

Health and Human Services Secretary Robert F. Kennedy Jr. said in an X post on Wednesday that the FDA will remove 12 peptides from the category of drug substances with significant safety risks.

Technology – AI, chips, software, cloud

Healthcare – Pharma, biotech, medical devices

Financials – Banks, payments, fintech

Energy – Oil, gas, renewables, uranium

Which sector are you most interested in deploying capital into right now?

Stocktwits

Stocktwits Polls

High short interest, massive call volume, and bullish sentiment have traders bracing for a potential violent move upward.

FDA moves to reclassify various peptides have investors viewing this as a critical growth catalyst for long-term health platforms.

Traders are reacting to Bank of America lifting its price target and citing new optionality in the company's growth pipeline.

Technicians are monitoring critical price levels like $27 and $30 for a breakout that could validate sustained bullish momentum.

HIMS
Hims & Hers Health Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest HIMS News

HIMSHims & Hers Health Inc